Menu UF Health Home Menu
 

Welcome

Cellular diagramFor the past nearly three decades, Dr. Srivastava’s research has been focused on the following two parvoviruses, the non-pathogenic adeno-associated virus (AAV), and a common human pathogen, the parvovirus B19, and the development of recombinant parvovirus vectors for human gene therapy.

More recently, the next generation of recombinant AAV vectors has been developed that transduce cells and tissues more efficiently at lower vector doses. The current emphasis is on developing recombinant parvovirus vectors for gene therapy for genetic diseases such a B-thalassemia and sickle cell disease, and malignant disorders such as erythroleukemia, hepatoblastoma and hepatocellular carcinoma.

UF Pediatrics NewsSubscribe to this RSS Feed

UF Health and Stop Children’s Cancer renew $1 million pledge to support pediatric cancer clinical trials

April 12, 2017

On Tuesday, April 11, 2017, Stop Children’s Cancer leaders and board members, along with Dr. Scott Rivkees, Dr. Parker Gibbs, Ed Jimenez and others from the UF Department of Pediatrics […]

UF Diabetes Research

March 31, 2017

New research from the University of Florida holds promise in the treatment of type one diabetes, researchers say.